Mass defect filter technique combined with stable isotope tracing for drug metabolite identification using high-resolution mass spectrometry
Authors:
- 8 April 2022
- journal article
- research article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1208, 339814
Abstract
No abstract availableKeywords
Funding Information
- Ditmanson Medical Foundation Chia-Yi Christian Hospital
- Ministry of Science and Technology, Taiwan (MOST 110-2320-B-705-001)
This publication has 17 references indexed in Scilit:
- Identification of Di-isononyl Phthalate Metabolites for Exposure Marker Discovery Using In Vitro/In Vivo Metabolism and Signal Mining Strategy with LC-MS DataAnalytical Chemistry, 2011
- Identification of Novel Metabolic Pathways of Pioglitazone in Hepatocytes: N-Glucuronidation of Thiazolidinedione Ring and Sequential Ring-Opening PathwayDrug Metabolism and Disposition, 2010
- A statistical procedure to selectively detect metabolite signals in LC-MS data based on using variable isotope ratiosJournal of the American Society for Mass Spectrometry, 2010
- Mass defect filter technique and its applications to drug metabolite identification by high‐resolution mass spectrometryJournal of Mass Spectrometry, 2009
- Metabolism and Toxicity of Drugs. Two Decades of Progress in Industrial Drug MetabolismChemical Research in Toxicology, 2007
- Second-Generation Thiazolidinediones and HepatotoxicityAnnals of Pharmacotherapy, 2004
- A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analysesJournal of Mass Spectrometry, 2003
- Identification of novel metabolites of pioglitazone in rat and dogXenobiotica, 2003
- Pioglitazone-associated fulminant hepatic failureAmerican Journal of Gastroenterology, 2002
- Synthesis and Biological Activity of Metabolites of the Antidiabetic, Antihyperglycemic Agent PioglitazoneJournal of Medicinal Chemistry, 1996